Status: Not yet recruiting
Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects
This is a first-in-human, randomized, double-blind, placebo-controlled clinical study to evaluate the Safety and Tolerability of SPOT-mRNA01 injection in healthy adult volunteers.
Participants needed: 10
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: SIPO Biotechnology Co. Ltd.Updated: Apr 23, 2026
Eligibility criteria
Any transient or chronic skin condition, disorder, or infection within 20 cm of... [+8]